Correlation Between Pfizer and ENTERPRISE

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pfizer and ENTERPRISE at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and ENTERPRISE into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc and ENTERPRISE PRODS OPER, you can compare the effects of market volatilities on Pfizer and ENTERPRISE and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of ENTERPRISE. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and ENTERPRISE.

Diversification Opportunities for Pfizer and ENTERPRISE

0.74
  Correlation Coefficient

Poor diversification

The 3 months correlation between Pfizer and ENTERPRISE is 0.74. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and ENTERPRISE PRODS OPER in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ENTERPRISE PRODS OPER and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with ENTERPRISE. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ENTERPRISE PRODS OPER has no effect on the direction of Pfizer i.e., Pfizer and ENTERPRISE go up and down completely randomly.

Pair Corralation between Pfizer and ENTERPRISE

Considering the 90-day investment horizon Pfizer Inc is expected to under-perform the ENTERPRISE. But the stock apears to be less risky and, when comparing its historical volatility, Pfizer Inc is 32.65 times less risky than ENTERPRISE. The stock trades about -0.08 of its potential returns per unit of risk. The ENTERPRISE PRODS OPER is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  9,728  in ENTERPRISE PRODS OPER on September 4, 2024 and sell it today you would earn a total of  92.00  from holding ENTERPRISE PRODS OPER or generate 0.95% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy90.91%
ValuesDaily Returns

Pfizer Inc  vs.  ENTERPRISE PRODS OPER

 Performance 
       Timeline  
Pfizer Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pfizer Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's technical and fundamental indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.
ENTERPRISE PRODS OPER 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days ENTERPRISE PRODS OPER has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, ENTERPRISE is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Pfizer and ENTERPRISE Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pfizer and ENTERPRISE

The main advantage of trading using opposite Pfizer and ENTERPRISE positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, ENTERPRISE can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ENTERPRISE will offset losses from the drop in ENTERPRISE's long position.
The idea behind Pfizer Inc and ENTERPRISE PRODS OPER pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.

Other Complementary Tools

Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Stocks Directory
Find actively traded stocks across global markets
Equity Valuation
Check real value of public entities based on technical and fundamental data
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities